Innovative Research Award
Mehmet Kizilkaya
Trabzon Kanuni Training and Research Hospital, Turkey
Mehmet Kizilkaya and places his documented publication activity within the broader field of cancer-related research. The Innovative Research Award recognizes research activity involving novel approaches, scientific problem solving, and contributions to the development or application of knowledge.[1][2]
Abstract
Mehmet Kizilkaya is presented in this recognition profile as a researcher working in the cancer biology and oncology-related research domain. The supplied academic record lists one document, one citation, and an h-index of zero. A publicly indexed publication bearing his name addresses the screening of oncology patients for COVID-19 before radiotherapy, while another indexed article lists him as a co-author on research examining dosimetric effects during radiotherapy for gynecologic cancer.[1][2]
Keywords
Cancer Biology, Oncology, Radiation Oncology, Radiotherapy, Gynecologic Cancer, Cancer Research, Clinical Research, Medical Research, Dosimetry, Innovative Research.
Introduction
Cancer research encompasses biological, clinical, diagnostic, therapeutic, and technological investigations directed toward improving the understanding and management of malignant disease. Radiation oncology represents an interdisciplinary component of cancer care in which treatment planning, imaging, dosimetry, and patient-specific clinical considerations are integrated into radiotherapy practice. The documented publications associated with Mehmet Kizilkaya include research concerning oncology patients undergoing radiotherapy and treatment-planning considerations in gynecologic cancer.[1][2]
Research Profile
The supplied profile identifies Mehmet Kizilkaya with Trabzon Kanuni Training and Research Hospital in Turkey and places the research subject area within Cancer Biology. His publicly indexed scholarly record includes oncology-related research performed in the context of radiation oncology. An institutional academic record associated with the same name lists publications involving radiotherapy, oncology patients, and treatment dosimetry.[1][2]
- Research area supplied for this recognition profile: Cancer Biology.
- Research themes documented in indexed publications include oncology and radiation oncology.
- Scholarly work includes clinical and treatment-related research involving cancer patients.
- Google Scholar profile identifier: LoT5L1kAAAAJ.
Research Contributions
One documented contribution is the 2022 publication Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. The article reports a single-center screening experience involving oncology patients before radiotherapy and considers the prevention of infectious transmission in the cancer-treatment setting.[1]
A further publication, appearing in the Turkish Journal of Oncology in 2025, lists Mehmet Kizilkaya among its authors and examines the dosimetric effects of bladder and rectum filling in patients with gynecologic cancer receiving adjuvant radiotherapy. The study was published with DOI 10.5505/tjo.2024.4429.[2]
Publications
- Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. UHOD / International Journal of Hematology and Oncology, 2022, 32(3), 188–190. DOI: 10.4999/uhod.226389.[1]
- Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 2025, 40(1), 11–19. DOI: 10.5505/tjo.2024.4429.[2]
The publication record should be interpreted together with the researcher’s complete scholarly profile because individual database records may differ in coverage, indexing dates, author disambiguation, and citation updating. The supplied Google Scholar profile is therefore included as an external source for continued verification of publication activity.[3]
Research Impact
The supplied bibliometric information records one document, one citation, and an h-index of zero. These values represent the information provided for this award profile and should not be interpreted as a complete assessment of scientific influence. Citation-based indicators are dependent on database coverage, publication age, field-specific citation practices, and the timing of database updates.[3]
The documented oncology publications nevertheless provide evidence of participation in clinical research addressing radiotherapy practice and cancer-patient management. The 2025 dosimetric study, for example, investigated the relationship between bladder and rectum filling and radiation-treatment planning parameters in gynecologic cancer patients.[2]
Award Suitability
The Innovative Research Award profile is based on documented research participation, subject relevance, publication activity, and the supplied academic identifiers. Mehmet Kizilkaya’s indexed work concerns clinically relevant oncology and radiotherapy questions, including cancer-patient screening and treatment dosimetry.[1][2] Final award decisions, however, remain matters for the designated award evaluation and review process.
Conclusion
Mehmet Kizilkaya’s documented research activity includes contributions to oncology and radiation-oncology research. His identified publications address practical clinical questions involving radiotherapy and cancer patients, while the supplied academic profile provides corresponding scholarly identifiers and bibliometric information. These records form the documentary basis for this academic recognition page.[1][2][3]
External Links
References
- Kizilkaya, M., Genc, M., Aksu, M. G., Koca, T., & Korcum, A. F. (2022). Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. International Journal of Hematology and Oncology, 32(3), 188–190.
https://doi.org/10.4999/uhod.226389
- Koca, T., Aksoy, R. A., Atak, E., Kizilkaya, M., Bilek, Y., Tunçel, N., Sarpün, İ. H., & Korcum, A. F. (2025). Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 40(1), 11–19.
https://doi.org/10.5505/tjo.2024.4429
- Google Scholar. (n.d.). Mehmet Kizilkaya — Google Scholar profile. Google Scholar.
https://scholar.google.com/citations?user=LoT5L1kAAAAJ&hl=tr
- ORCID. (n.d.). Mehmet Kizilkaya — ORCID record. ORCID.
https://orcid.org/0000-0003-0266-3919
- International Molecular Biologist Awards. (n.d.). Official Award Website.
https://molecularbiologist.org/